This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Man Gao: Innovator in Prion-Specific Peptoid Reagents
Introduction
Man Gao is a notable inventor based in San Ramon, California. She has made significant contributions to the field of biotechnology, particularly in the development of reagents that target prion-related diseases. Her innovative work has the potential to impact the detection and treatment of these conformational disease proteins.
Latest Patents
Man Gao holds a patent for "Prion-specific peptoid reagents." This invention relates to peptoid reagents that interact preferentially with a pathogenic form of a conformational disease protein compared to its nonpathogenic counterpart. The peptoid reagent comprises an amino-terminal region, a carboxy-terminal region, and at least one peptoid region containing 3 to about 30 N-substituted glycines, along with optional amino acids. The invention also includes methods for using these peptoids in detecting and isolating prions, as well as in the treatment and prevention of prion-related diseases. She has 1 patent to her name.
Career Highlights
Man Gao is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to further her research and development efforts in the field of prion-related diseases.
Collaborations
Throughout her career, Man Gao has collaborated with esteemed colleagues, including David Peretz and Michael D. Connolly. These collaborations have enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Man Gao is a pioneering inventor whose work in prion-specific peptoid reagents showcases her commitment to addressing critical health challenges. Her contributions to biotechnology are significant and hold promise for future advancements in the detection and treatment of prion-related diseases.